EMA concludes "possible link" between AstraZeneca vaccine and clots

in Noticias, COVID-19, Europa · 07-04-2021 17:33:00 · 0 Comentarios

The European Medicines Agency (EMA) concluded today that there is a "possible relationship" between the covid-19 vaccine by the pharmaceutical company AstraZeneca and the formation of "very rare cases" of blood clots, but insisted on the benefits of the jab.

In particular, the EMA safety committee "concluded today that unusual blood clots with low blood platelets should be listed as very rare side effects” of the AstraZeneca vaccine, taking into account "all the evidence currently available" following the investigation carried out in recent weeks.



Artículos relacionados


Comentarios:

Sé el primero en comentar este artículo
Temas interactivos, envíanos tus comentarios / opinión sobre este artículo.

Ten en cuenta que The Portugal News puede utilizar comentarios seleccionados en la edición impresa del periódico.